APTALIS PHARMA

aptalis-pharma-logo

Aptalis Pharma (known as Axcan Pharma until May 2011) is a privately-held, leading specialty pharmaceutical company that develops and markets a wide range of products to treat gastrointestinal diseases and disorders, such as inflammatory bowel disease, cholestatic liver diseases, irritable bowel syndrome, and complications related to pancreatic insufficiency. Aptalis hopes to improve the quality of care and health of patients suffering from gastrointestinal diseases and disorders by providing ef... fective therapies for patients and their specialized caregivers. Aptalis was acquired by [TPG Capital](/organization/tpg-capital) in 2008, and it acquired [Eurand](/organization/eurand) in 2010. It [changed its name](http://www.thepressreleasewire.com/client/aptalispharma/release.jsp?actionFor=1437343&releaseSeq=0&year=2011) from Axcan Pharma to Aptalis in May 2011.

#SimilarOrganizations #People #Financial #Website #More

APTALIS PHARMA

Social Links:

Industry:
Biotechnology Developer Platform Therapeutics

Founded:
1982-01-01

Address:
Bridgewater, New Jersey, United States

Country:
United States

Website Url:
http://www.aptalispharma.com

Total Employee:
501+

Status:
Closed

Contact:
(800) 678-1605

Email Addresses:
[email protected]

Total Funding:
170.47 K USD

Technology used in webpage:
SPF LetsEncrypt Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Level 3 Communications Bell Canada Videotron Taleo GTT Communications


Similar Organizations

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.


Current Advisors List

todd-sisitsky_image

Todd Sisitsky Member of the Board of Directors @ Aptalis Pharma
Board_member

Current Employees Featured

david-w-mims_image

David W. Mims
David W. Mims Executive Vice President and COO @ Aptalis Pharma
Executive Vice President and COO

Founder


frank-verwiel_image

Frank Verwiel

Acquisitions List

Date Company Article Price
2010-12-01 Eurand Eurand acquired by Aptalis Pharma 583 M USD
2001-11-17 Laboratoires Entรฉris Laboratoires Entรฉris acquired by Aptalis Pharma N/A

Official Site Inspections

http://www.aptalispharma.com

  • Host name: 159.180.132.176
  • IP address: 159.180.132.176
  • Location: North Chicago United States
  • Latitude: 42.325
  • Longitude: -87.8561
  • Metro Code: 602
  • Timezone: America/Chicago
  • Postal: 60064

Loading ...

More informations about "Aptalis Pharma"

Aptalis - Wikipedia

Aptalis was a company in the pharmaceutical industry. In January 2014, the company was acquired by Forest Laboratories (acquired by Allergan) for $675 million. Through a series of acquisitions, the company is now a contract development and manufacturing organization and rebranded as Adare Phama Solutions, headquartered in Lawrenceville, New Jersey. See details»

Aptalis Pharma - Crunchbase Company Profile & Funding

Aptalis Pharma (known as Axcan Pharma until May 2011) is a privately-held, leading specialty pharmaceutical company that develops and markets a wide โ€ฆSee details»

Aptalis Pharma - LinkedIn

Aptalis Pharma Inc. is a privately held, leading specialty pharmaceutical company providing innovative, effective therapies for unmet medical needs including cystic fibrosis and gastrointestinal ...See details»

Axcan & Eurand Announce Name Change - Drug Development โ€ฆ

Aptalis Pharma also has a new corporate logo and website: www.APTALISPharma.com. โ€œOur new name, Aptalis, is intended to capture the essence of two great companies that have โ€ฆSee details»

Aptalis Pharma Canada ULC - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Aptalis Pharma Canada ULC of Mont-Saint-Hilaire, QC. Get the latest business insights from Dun & โ€ฆSee details»

About: Aptalis - DBpedia Association

Jan 1, 2011 Aptalis was a company in the pharmaceutical industry. In January 2014, the company was acquired by Forest Laboratories (acquired by Allergan) for $675 million. โ€ฆSee details»

APTALIS PHARMA US, INC. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for APTALIS PHARMA US, INC. of Bridgewater, NJ. Get the latest business insights from Dun & Bradstreet.See details»

Aptalis Pharma Srl - Company Profile and News - Bloomberg โ€ฆ

Company profile page for Aptalis Pharma Srl including stock price, company news, executives, board members, and contact informationSee details»

Aptalis Pharma | IT History Society

Aptalis Pharma develops and markets therapies for the treatment of gastrointestinal diseases and disorders.Aptalis Pharma (known as Axcan Pharma until May 2011) is a privately-held, leading โ€ฆSee details»

Aptalis Pharma Srl: Drug pipelines, Patents, Clinical trials - Synapse

Explore Aptalis Pharma Srl with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 17 news, and 13 literature, Technology Platform:Animal extract, Drug:Pancrelipase(Eurand).See details»

Aptalis Pharma - PitchBook

Aptalis Pharma was founded in 1982. Where is Aptalis Pharma headquartered? Aptalis Pharma is headquartered in Bridgewater, NJ. What is the size of Aptalis Pharma? Aptalis Pharma has โ€ฆSee details»

The Newly Combined Axcan and Eurand Announce Name Change โ€ฆ

BRIDGEWATER, N.J., May 6, 2011 /PRNewswire/ -- Axcan Intermediate Holdings Inc. announces that it is changing its name to Aptalis Pharma. The rebranding follows the recently โ€ฆSee details»

Aptalis Pharma Canada ULC - Company Profile and News

Aptalis Pharma Canada, ULC operates as a pharmaceutical company. The Company develops medicines for patients suffering from diseases including gastroenterology, women's health, โ€ฆSee details»

Forest Laboratories to Acquire Aptalis - Pharmaceutical Technology

Aptalis has signed a definitive agreement to be acquired by Forest Laboratories, a leading, fully integrated, specialty pharmaceutical company, for $2.9bn in cash pending required reviews. โ€ฆSee details»

Aptalis Pharma - Contacts, Employees, Board Members

Organization. Aptalis Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... and Advisor Profiles 1. About. Aptalis โ€ฆSee details»

Aptalis - Overview, News & Similar companies | ZoomInfo.com

Jul 18, 2022 View Aptalis (www.aptalispharmaceuticaltechnologies.com) location , revenue, industry and description. Find related and similar companies as well as employees by ...See details»

The Newly Combined Axcan and Eurand Announce Name Change โ€ฆ

May 6, 2011 Aptalis Pharma also has a new corporate logo and website (please visit us at www.aptalispharma.com). "Our new name, Aptalis, is intended to capture the essence of two โ€ฆSee details»

Aptalis to be Acquired by Forest Laboratories for $2.9 Billion

Jan 8, 2014 For Aptalis: Colleen White Senior Director, Corporate Communications [email protected] O: 908-429-4479, ext. 4023; C: 908-552-9606 or For TPG: Lisa โ€ฆSee details»

What is Aptalis Pharma? Company Culture, Mission, Values

See what employees say it's like to work at Aptalis Pharma. Salaries, reviews, and more - all posted by employees working at Aptalis Pharma.See details»

Aptalis โ€” The "Three Ms" Of Specialty Pharma

Jul 1, 2013 Aptalis Pharma US (Aptalis) serves as both example and exception in shedding light on the SP sector. The companyโ€™s president and CEO, Frank Verwiel, M.D., coined the โ€œthree โ€ฆSee details»

linkstock.net © 2022. All rights reserved